Asclepii: Detailed Company Information & Corporate Profile
Contact top employees from
Asclepii
Summary
The business currently specializes in Medical Devices area. The company has 10-50 employees. Register with SignalHire to connect with Asclepii employees and management.
| Asclepii Website | asclepii.com |
| Phone Number | 2166728568 |
| Industries | |
| Asclepii Headquarters address | Cleveland, OH, 44106 US |
| Company Size | 10-50 employees |
| Specialties | Medical Devices, Wound healing, Drug delivery, Stem Cells, MedTech |
| Founded | 2022 |
Workforce Turnover
Length of Employment
Asclepii's workforce includes employees across a wide range of tenure levels.
67% have been with the company for 1 to 2 years33% have been with the company for 3 to 4 yearsContact top employees from
Asclepii
Franco KraiselburdFounder & CEO
GREGORY BENDEWALDChief Commercial Officer
Eduardo AndradeAngel Investor
Brian KrattDirector of R&D Operations
Miguel Fuentes ChandiaChief Scientific Officer and founder
Kianna VerdugoResearch And Development Intern
Ixchel Robles RuizChief Operations Officer
Manuel Rocha PereyraDirector of Finance
Isabel VazquezResearch And Development Intern
Companies Similar to Asclepii
Asclepii Corporate Information: FAQ
Asclepii operates in the Medtech industries. More details can be found on the official website: asclepii.com.
Asclepii has offices located in Cleveland, US.
The headquarters of Asclepii are located in Cleveland, United States.
You can contact Asclepii by phone at 2166728568.
Asclepii currently employs 10-50 people.
Asclepii's revenue is approximately 6.8M.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
